AstraZeneca Blames Germany’s Tender System For Influenza Vaccine Shortages
This article was originally published in The Pink Sheet Daily
Executive Summary
AstraZeneca says that shortages of influenza vaccines in Germany are a direct result of the tendering process there, which has blocked the firm’s Fluenz nasal spray product from being prescribed in several federal states.